Skip to main content

Call for papers - Advances in mycotherapy

Guest Editors

Wong Kah Hui, PhD, Universiti Malaya, Malaysia
I-Chen Li, PhD, Grape King Biotech Research Institute, Taiwan

Submission Status: Open   |   Submission Deadline: 25 November 2024


BMC Complementary Medicine and Therapies is calling for submissions to our collection on Advances in mycotherapy.

This collection welcomes studies that investigate the bioactive compounds, pharmacological properties and potential therapeutic applications of medicinal mushrooms. We also welcome studies that evaluate the efficacy and safety of mycotherapy along with regulatory challenges of the commercialization of mycotherapeutic products. Observational studies that look at prevalence, patterns of use, and ethnomycological insights into the use of mushrooms as medicine are also of interest.

Meet the Guest Editors

Back to top

Wong Kah Hui, PhD, Universiti Malaya, Malaysia

Wong Kah Hui is an Associate Professor at the Department of Anatomy, Faculty of Medicine, Universiti Malaya. Her research focuses on using alternative medicines, in particular the culinary and medicinal mushrooms cultivated in Malaysia for neuroprotection and neuroregeneration in cellular and animal models. She is engaged with Ganofarm R&D Private Limited to pursuit scientific research leading to management for hereditary ataxia using Hericium erinaceus mushroom dietary supplement (NevGro®). As a team leader, her research group was granted with 10 awards at various international invention and innovation exhibitions with Tackling Movement Disorders with NevGro® being the latest innovation that struck a gold medal at the 34th International Invention, Innovation & Technology Exhibition, ITEX 2023.

I-Chen Li, PhD, Grape King Biotech Research Institute, Taiwan

I-Chen Li is Deputy Section Manager at the Grape King Biotech Company, the largest functional food manufacturer with 506 tons capacity in Taiwan. Major research focus is on fermented medicinal mushrooms for health and wellness with an emphasis on the roles of discovery of novel bioactive metabolites to ameliorate various diseases. Li received her PhD in 2022 and has an outstanding publication record, comprising 31 publications (21 first author) in peer-reviewed international journals and 14 international patents.

About the Collection

BMC Complementary Medicine and Therapies is calling for submissions to our collection on Advances in mycotherapy. 

This collection welcomes studies that investigate the bioactive compounds, pharmacological properties and potential therapeutic applications of medicinal mushrooms. We also welcome studies that evaluate the efficacy and safety of mycotherapy along with regulatory challenges of the commercialization of mycotherapeutic products. Observational studies that look at prevalence, patterns of use, and ethnomycological insights into the use of mushrooms as medicine are also of interest.

The field of mycotherapy focuses on the development of extracts and compounds obtained from mushrooms for medicines or supplements. However, for centuries, mushrooms have been a key player in traditional medicine. The discovery of penicillin in 1928 gave way to our capability to extract and identify active ingredients of mushrooms. Modern medical research has shed light on the numerous pharmacological actions of mushrooms, including antimicrobial, anti-inflammatory, antioxidant and antidiabetic, to name a few. Uncovering and characterizing further the potential medical benefits of mushrooms along with its safety profile is essential to supplement the growing interest of medicinal mushrooms as adjuvants to conventional therapies. Given its ancient history and remarkable resilience, mycotherapy emerges as a field deserving significant attention.

Image credit: AscentXmedia / Getty Images / iStock

  1. Osimertinib is regarded as a promising third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for advanced non-squamous non-small cell lung cancer (NSCLC) patients who develop...

    Authors: Tong-Tong Wu, Yu-Yi Chen, Zi-Chun Yuan, Guo-Wang Yang and Gan-Lin Zhang
    Citation: BMC Complementary Medicine and Therapies 2024 24:125
    Content type: Study Protocol Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Advances in mycotherapy" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.